Changes in Serum Intact Fibroblast Growth Factor 23 Concentrations From Midlife to Late Life and Their Predictors in the Community: The ARIC Study

Objective: To investigate longitudinal changes in the blood concentration of fibroblast growth factor 23 (FGF23) from midlife to late life and their major predictors in the general population. Patients and Methods: In 14,444 participants of the Atherosclerosis Risk in Communities Study, we analyzed...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Junichi Ishigami, MD, MPH, Yasuyuki Honda, MD, Amy B. Karger, MD, PhD, Josef Coresh, MD, PhD, Elizabeth Selvin, PhD, MPH, Pamela L. Lutsey, PhD, MPH, Kunihiro Matsushita, MD, PhD
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2022-06-01
Colección:Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Acceso en línea:http://www.sciencedirect.com/science/article/pii/S2542454822000133
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares